EcoDrugPlus

Ribosomal Protein Lateral Stalk Subunit P0

Ensembl ID : ENSAPOG00000003585
Gene Symbol: RPLP0
3 Cross references
403 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P1

Ensembl ID : ENSAPOG00000015519
Gene Symbol: RPLP1
3 Cross references
386 Possible Orthologues:

Selectin E

Ensembl ID : ENSAPOG00000001588
Gene Symbol: SELE
2 Cross references
179 Possible Orthologues:

Selectin P

Ensembl ID : ENSAPOG00000001572
Gene Symbol: SELP
2 Cross references
169 Possible Orthologues:

Serine/threonine-Protein Kinase Pak 4-Like

Ensembl ID : ENSAPOG00000013944
Gene Symbol: LOC110953871
3 Cross references
163 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-1-Like

Ensembl ID : ENSAPOG00000007560
Gene Symbol: LOC110965263
3 Cross references
249 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-1-Like

Ensembl ID : ENSAPOG00000000911
Gene Symbol: LOC110963111
3 Cross references
249 Possible Orthologues:

Serpin Family C Member 1

Ensembl ID : ENSAPOG00000006378
Gene Symbol: SERPINC1
3 Cross references
202 Possible Orthologues:

Serum Amyloid P-Component-Like

Ensembl ID : ENSAPOG00000011163
Gene Symbol: LOC110947130
2 Cross references
385 Possible Orthologues:

Serum Amyloid P-Component-Like

Ensembl ID : ENSAPOG00000004512
Gene Symbol: LOC110952958
2 Cross references
352 Possible Orthologues:

Serum Amyloid P-Component-Like

Ensembl ID : ENSAPOG00000011249
Gene Symbol: LOC110947121
2 Cross references
385 Possible Orthologues:

Si:dkey-211g8.6

Ensembl ID : ENSAPOG00000012454
Gene Symbol: SI:DKEY-211G8.6
1 Cross references
319 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).